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ABSTRACT   Age-related macular degeneration (AMD) is the major cause of blindness 
and reduced vision among adults in Japan, for which only symptomatic therapy using an 
anti-vascular endothelial growth factor (anti-VEGF) drug is currently available. Recently, 
transplantation of retinal pigment epithelium (RPE) cells derived from human embryonic or 
pluripotent stem cells has been extensively applied in clinical practice as a radical therapy 
for patients with AMD; however, its therapeutic effect remains limited. RPE cells have 
melanin pigment granules that increase over time; moreover, the degree of pigmentation 
(dPG) increases with the number of pigment granules. The expression levels of RPE-specific 
genes and the secretion of cytokines reportedly increase as dPG increases. In this study, we 
performed functional characterization of human RPE (h-RPE) cells with low and high dPG 
to determine which might be suitable for transplantation to patients with AMD. Specifically, 
we isolated h-RPE cells with low and high dPG based on evaluation of lightness parameters, 
then characterized these cells separately. Our results showed that RPE cells with low dPG 
exhibited elevated phagocytosis and cell adhesiveness, as well as reduced VEGF secretion, 
compared with RPE cells with high dPG. Because these traits are considered preferable 
for transplantation to patients with AMD, RPE cells with low dPG may be more suitable for 
transplantation. Cellular senescence (indicated by levels of senescence-related proteins) was 
more advanced in RPE cells with high dPG, suggesting that cellular senescence is an important 
factor that contributes to the suitability of RPE cells for transplantation to patients with AMD.
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〈Regular Article〉
years, such that it has become an important retinal 
degenerative disease among the major causes of 
blindness１）. Currently, the gold standard therapy 
for AMD is vitreous injection of an anti-vascular 
endothelial growth factor (anti-VEGF) drug; 
INTRODUCTION
   Age-related macular degeneration (AMD) is 
the major cause of blindness and reduced vision 
among adults in developed countries. In Japan, the 
incidence of this disease has increased in recent 
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focal adhesion kinase, paxillin, and zyxin, as well as 
vinculin; staining for any of these proteins reportedly 
yields nearly the same number and morphology 
of cells. Thus, vinculin is considered to be a 
typical protein in the context of cell adhesiveness, 
which can be useful to assess this characteristic 
among cells10）. RPE cells are able to phagocytose 
photoreceptor outer segments, which is essential 
for maintenance of retinal homeostasis. Thus, a 
reduction in the ability of RPE cells to phagocytose 
photoreceptor outer segments is considered one 
of the causes of AMD11）. Moreover, RPE cells 
are able to secrete VEGF５）, which contributes to 
choroidal neovascularization in AMD; increased 
levels of VEGF in the eye are known to aggravate 
the macular degeneration observed in patients with 
AMD２）. Finally, aging has been strongly associated 
with a decline in RPE cell function. Large amounts 
of waste products, generated in connection with the 
decline in RPE cell function, reportedly accumulate 
in the macula with age12，13）.
   RPE cells are characterized by the presence of 
melanin pigment granules that increase over time. 
The degree of pigmentation (dPG) in RPE cells 
increases with the extent of pigment granules14）. 
In addition, the expression levels of RPE-specific 
genes and the levels of secreted cytokines reportedly 
increase with increasing dPG in RPE cells; 
therefore, dPG is regarded as an indicator of RPE 
maturity15）.
   In this study, we attempted to address the problem 
whereby transplantation of RPE cells cannot 
improve the visual acuity of patients with AMD; 
thus, we presumed that the transplantation of 
RPE cells with suitable quality would contribute 
to improved visual function in patients with 
AMD.We hypothesized that cells with high dPG 
would exhibit improved functional characteristics 
(e.g., focal contacts, phagocytic capacity, VEGF 
secretion) that might be suitable for transplantation. 
Accordingly, we characterized human RPE (h-RPE) 
however, this only constitutes symptomatic therapy, 
such that remission and withdrawal are unlikely２，３）. 
Additionally, this therapy is occasionally ineffective. 
Notably,  ret inal  pigment epithelium (RPE) 
transplantation has attracted great attention as a 
radical therapy for patients with AMD. Impaired 
RPE function is presumed to underlie the pathology 
of AMD. RPE transplantation is able to replenish 
impaired RPE with healthy RPE. In recent years, 
transplantation using RPE cells derived from human 
embryonic stem cells or from human pluripotent 
stem cells has been extensively applied in clinical 
practice. A 1-year follow-up study conducted in 
2014, regarding the transplantation of human 
pluripotent stem cell-based RPE into patients with 
AMD, found no recurrences of exudative changes 
in the macula, indicating a generally good quiescent 
condition４，５）. However, visual function of recipient 
patients remains poor after RPE transplantation６）. 
To achieve improved visual function after RPE 
transplantation, there is a need to define the 
characteristics of RPE cells that are optimal for 
transplantation. 
   T h e r e  a r e  t w o  m e t h o d s  f o r  s u b r e t i n a l 
t r a n s p l a n t a t i o n  o f  R P E  c e l l s :  c e l l  s h e e t 
transplantation and sub-retinal injection of cell 
suspension５，７，８）. Cell sheets exhibit good cell 
adhesiveness; however, they are highly invasive 
because they can be up to 1.3 × 3 mm in size, thus 
requiring insertion through retinal incisions of 1.8 
mm５）. In contrast, cell suspension transplantation 
allows sub-retinal administration with 38-gauge 
needles７） and is less invasive; these characteristics 
have led to its use as a mainstream surgical 
technique. However,  low cell  adhesiveness 
is a potential  l imitation of cell  suspension 
transplantation８）. 
   A key aspect of cell adhesion involves focal 
contacts. Vinculin proteins form focal contacts, 
which are used as indicators of cell adhesion９）. Cell 
focal adhesions are composed of proteins such as 
51Setoguchi Y, et al. : Functional assessment of RPE transplants based on dPG
cells with low and high dPG, in terms of their focal 
contacts, phagocytic capacity, VEGF secretion; we 
aimed to establish a dPG level in RPE cells that is 
functionally suitable for transplantation to patients 
with AMD.
MATERIALS AND METHODS
Culture of h-RPE cells
   h-RPE cells were purchased from Lonza (Basal, 
Switzerland) and cultured on CELLstart-coated 
dishes (GIBCO, Grand Island, NY, USA) in pre-
confluent medium (F10; Sigma-Aldrich, St. Louis, 
MO, USA) with 10% fetal bovine serum) before 
reaching confluence. After reaching confluence, 
h-RPE cells were cultured in postconfluent 
medium (DMEM/F12 (7:3) supplemented with 
B27 (Invitrogen, Carlsbad, CA, USA), 2 mM 
L-glutamine (Sigma-Aldrich), and 10 ng/ml basic 
fibroblast growth factor (Wako, Osaka, Japan).
Evaluation of the dPG in h-RPE cells
   The methods used for evaluation of the dPG 
in h-RPE cells were performed as previously 
described15）. The RGB value was measured by 
assessment of the light transmittances at different 
wavelengths (blue, 436 nm; green, 546 nm; red, 700 
nm) using an absorption spectrometer (Varioskan 
Flash®; Thermo Fisher Scientific, Waltham, MA, 
USA). The RGB value was rearranged on the basis 
of the hue, saturation, and value color system, in 
accordance with the equation provided in previous 
reports16）. The lightness of the hue, saturation, and 
value color system was used to evaluate the dPG 
in h-RPE cells; the dPG value ranged from 0 to 
100, with the blank set as 100. h-RPE cells were 
classified into two groups: low dPG (≥ 65) and high 
dPG (<50). Low- and high-dPG cells were obtained 
from a single donor.
Luminescence assay
   h-RPE cells were seeded at a density of 1.0×
105 cells/cm2 on 96-well plates. After they had been 
incubated at 37℃ under 5% CO2 atmosphere for 
24 hr, cells were mixed with 100 μl/well CellTiter-
GlO® (Promega, Madison, WI, USA). The plates 
were incubated at room temperature for 10 min in 
the dark. Relative luminescence units (RLUs) were 
measured by using a multimode microplate reader 
(Varioskan Flash®; Thermo Fisher Scientific).
Immunofluorescence assay
   The methods used for vinculin immunocytochemistry 
were previously described17）. h-RPE cells were 
seeded at a density of 1.0×104 cells/cm2 on 96-
well plates. After they had been incubated at 
37℃ under 5% CO2 atmosphere for 2 hr, cells 
were fixed with 4% paraformaldehyde (Sigma-
Aldrich) and permeabilized with 0.3% Triton 
X-100™ (Fisher Biotech, Hampton, NH, USA); they 
were then blocked with Blocking One® (Nacalai, 
Kyoto, Japan) for 60 minutes at room temperature. 
Vinculin was detected with a primary antibody 
(rabbit, 1:50 dilution; Cat. No. 700062, Thermo 
Fisher Scientific) overnight at 4℃ . Bound primary 
antibody was detected with Alexa Fluor 488-labeled 
goat anti-rabbit IgG secondary antibody (1:500 
dilution, Cat. No. A27034, Invitrogen). Vinculin-
positive focal contacts in each cell were counted 
using a fluorescence microscope (Olympus BX-53; 
Olympus, Tokyo, Japan).
Phagocytosis assay
   h-RPE cells were seeded at a density of 1.0
×105 cells/cm2 on 24-well plates. Fluorescein 
isothiocyanate-labeled beads were added at a final 
concentration of 2.0×106 beads/ml. After cells 
and beads had been incubated at 37℃ under 5% 
CO2 atmosphere for 48 hr, fluorescence-activated 
cell sorting (FACS) analysis was performed using 
The BD FACSCanto ™ Ⅱ flow cytometer (Becton 
Dickson, Franklin Lakes, NJ, USA) to measure 
the rate of fluorescent bead phagocytosis. FACS 
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was performed after cells had been washed with 
phosphate-buffered saline to remove beads that 
were bound to the cell surface, but had not been 
phagocytosed. FACS data were analyzed using 
FlowJo™ software (FlowJo, Ashland, OR, USA).
Quantitative reverse transcription polymerase chain 
reaction
   Total RNA was extracted from h-RPE cells 
using an RNeasy Plus Mini kit® (Qiagen, Hilden, 
Germany), in accordance with the manufacturer’s 
instructions. RNA concentration and quality were 
assessed with a NanoDrop 1000 spectrophotometer 
(Thermo Fisher Scientific). RNA was reverse 
transcribed in a 20-μl reaction containing 11 
μl of RNA (1000 ng) in DNase- and RNase-
free water (Qiagen), 1 μl of 50 μM Oligo (dT) 
20  (Invitrogen), 1  μl  of 10  mM dNTP Mix 
(Invitrogen), 1  μl  of RNaseOUT (20  U/μl; 
Invitrogen), and SuperScript™ Ⅲ Reverse Transcriptase 
(4 μl of 5× First-Standard Buffer, 1 μl of 0.1 M 
dithiothreitol, and 1 μl of SuperScript Ⅲ at 200 U/
μl; Invitrogen). cDNA synthesis was performed 
using the following reaction conditions: 5 min 
at 25℃, 60 min at 50℃, and 15 min at 70℃. 
Quantitative reverse transcription polymerase chain 
reaction reactions were performed using Ex Taq® 
DNA polymerase (Takara Bio, Shiga, Japan) and 
SYBRTM Green master mix (Applied Biosystems, 
Foster City, CA, USA). The following thermal 
cycling conditions were applied: one cycle at 50℃ 
for 120 sec and 95℃ for 120 sec, followed by 
40 cycles at 95℃ for 15 sec and 58℃ for 60 sec. 
Relative expression levels of MERTK, an RPE-
specific gene, were determined using the 2－ ( △△ Ct) 
method. The following forward and reverse primer 
sequences (Fasmac, Kanagawa, Japan) were 
used to amplify the MERTK  gene: forward, 
AGGTTGAAGCAGCCCGAAGA; reverse , 
TGCTTGGTTCCGAACGTCAG.
Enzyme-linked immunosorbent assay (ELISA) for 
measurement of VEGF secretion
   The culture medium from confluent h-RPE cells 
was collected 24 hr after the medium was changed. 
Secretion levels were measured using a human 
VEGF-ELISA kit (eBioscience, San Diego, CA, 
USA), following the manufacturers’ instructions.
Senescence assay
   h-RPE cells were seeded at a density of 1.0×
105 cells/cm2 on 96-well plates. In accordance 
with the manufacturer’s instructions, a human IL-6 
ELISA kit (R & D Systems, Minneapolis, MN, 
USA) and a 96-well Cellular Senescence Assay® 
(Cell Biolabs, San Diego, CA, USA) were used 
to measure IL-6 expression and Sa-βG activity, 
respectively. Absorption of 450 nm light was used 
to measure the expression of IL-6; fluorescence 
at 360 nm (excitation) / 465 nm (emission) was 
used to measure the expression of Sa-βG. Both 
measurements were performed using a multimode 
microplate reader (Varioskan Flash®; Thermo Fisher 
Scientific).
Statistical Analysis
   Data were analyzed with the BellCurve for Excel 
(Social Survey Research Information Co., Ltd., 
Tokyo, Japan).Values are expressed as the mean 
± standard error of the mean, and differences with 
P < 0.05 were considered statistically significant. 
Phagocytosis, luminescence, vinculin, VEGF 
secretion, and senescence assays were evaluated 
using the Mann-Whitney U test. Relative MERTK 
gene expression levels were analyzed by using 
paired t-tests. *P < 0.05; **P < 0.01
RESULTS
Cell adhesiveness
   To clarify the relationship between dPG and cell 
adhesion, a luminescence assay was used to assess 
the number of adherent cells among h-RPE cells 
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with low or high dPG. Luminescence values were 
89,954.8 ± 5,987.8 RLUs in the low dPG group 
and 44,928.6 ± 6,410.2 RLUs in the high dPG 
group; luminescence was significantly lower in 
the high dPG group (n = 5 per group, p = 0.0090; 
Fig. 1a). Vinculin immunocytochemistry was used 
to determine the number of vinculin proteins (i.e., 
typical constituents of focal contacts) in h-RPE cells 
with low or high dPG, which allowed us to examine 
the relationship between dPG and cell adhesion. 
The numbers of vinculin-positive focal contacts in 
each h-RPE cell were 11.6 ± 2.2 in the low dPG 
group and 3.7 ± 0.9 in the high dPG group; there 
were significantly fewer vinculin-positive focal 
contacts in each cell in the high dPG group (n = 11 
per group, p = 0.0036; Fig. 1b). Vinculin-positive 
focal contacts of a h-RPE cell were observed in 
fluorescence images (right panel, h-RPE cell with 
low dPG; left panel, h-RPE cell with high dPG; Fig. 
1c).
Fig. 1. Evaluation of cell adhesiveness
a. Luminescence assay. The numbers of adherent human retinal pigment epithelium (h-RPE) cells were measured at 24 hr after 
seeding (n = 5 per group).
b. Immunofluorescence assay. The numbers of vinculin-positive focal contacts per h-RPE cell were counted at 2 hr after seeding (n 
= 11 per group).
White dots, low degree of pigmentation (dPG) group; black dots, high dPG group
c. Staining of vinculin-positive focal contacts in fluorescence images of h-RPE cells. right panel, h-RPE cell with low degree of 
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Phagocytic capacity
   To examine the relationship between dPG and 
phagocytic capacity, the rates of phagocytosis of 
fluorescent beads were assessed in h-RPE cells with 
low or high dPG. Uptake of fluorescence labeled 
beads was measured by using FACS. The phagocytic 
rates were 16.9 ± 1.0% in the low dPG group and 
12.4 ± 0.8% in the high dPG group; uptake was 
significantly lower in the high dPG group (n = 6 per 
group, p = 0.0039; Fig. 2a). Quantitative reverse 
transcription polymerase chain reactions were used 
to determine mRNA levels of Mer tyrosine kinase 
(MERTK), a phagocytic marker, in h-RPE cells with 
low or high dPG, which allowed us to examine the 
relationship between dPG and phagocytic capability. 
The expression levels of MERTK, a marker of the 
phagocytic capacity of RPE cells, were evaluated 
using quantitative reverse transcription polymerase 
chain reaction assay. The expression level of 
MERTK was lower in the high dPG group than in 
the low dPG group (n = 9 per group, p<0.001; Fig. 
2b).
ELISA to measure VEGF secretion
   To examine the relationship between dPG and 
VEGF secretion, levels of VEGF were determined 




Fig. 2. Evaluation of phagocytic capacity
a. Uptake of fluorescence-labeled beads was measured by fluorescence-activated cell sorting (n = 6 per group).
b. Relative expression of MERTK mRNA was evaluated using quantitative reverse transcription polymerase chain reaction (n = 9 
per group).
White bar, low degree of pigmentation (dPG) group; black bar, high dPG group
Fig. 3. Assessment of vascular endothelial growth factor 
(VEGF) secretion
VEGF secretion was evaluated using enzyme-linked 
immunosorbent assay (n = 6 per group).
White bar, low degree of pigmentation (dPG) group; black 
bar, high dPG group
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ELISA analysis. Secretion of VEGF was evaluated 
using ELISA. The levels of VEGF were 12.3 ±
0.6 pg/ml in the low dPG group and 15.0 ± 0.5 pg/
ml in the high dPG group; secretion of VEGF was 
significantly lower in the low dPG group (n = 6 per 
group, p = 0.016; Fig. 3).
Cell senescence
   To clarify the relationship between dPG and cell 
senescence, levels of senescence-associated beta-
galactosidase (Sa-βG) and interleukin (IL)-6 were 
quantitatively analyzed in h-RPE cells with low or 
high dPG, by using a senescence assay. The level 
of cell senescence was examined by quantitation of 
IL-6 expression and Sa-βG activity. The expression 
levels of IL-6 were 281.1 ± 10.7 (pg/ml) in the low 
dPG group and 446.3 ± 19.4 (pg/ml) in the high 
dPG group; expression of IL-6 was significantly 
higher in the high dPG group (n = 6 per group, p 
= 0.0039; Fig. 4a). The relative fluorescence units 
of Sa-βG activity were 4.3 ± 0.3 in the low dPG 
group and 15.7 ± 0.5 in the high dPG group; Sa-
βG activity was significantly higher in the high 
dPG group (n = 7 per group, p = 0.002; Fig. 4b).
DISCUSSION
   This study aimed to determine the dPG in RPE 
cells that are suitable for transplantation to patients 
with AMD by separately assessing the functions 
of RPE cells with low and high dPG. Expression 
of the MERTK gene, a marker of the phagocytic 
capacity of RPE cells, was lower in RPE cells with 
high dPG, compared with RPE cells with low dPG. 
The rate of fluorescent bead phagocytosis and the 
capacity for cell adhesiveness were also lower in 
RPE cells with high dPG. Furthermore, secretion of 
VEGF, a key factor in the onset of AMD pathology, 
was enhanced in RPE cells with high dPG. These 
results suggest that the RPE cells with low dPG 
might be suitable for transplantation to patients with 
AMD, based on the cell biological data shown here. 
In addition, RPE cells with high dPG showed higher 
levels of cellular senescence markers (i.e., Sa-
βG activity and IL-6 expression), compared with 
RPE cells with low dPG; this finding indicated the 
advancement of senescence in RPE cells with high 
dPG, compared with RPE cells with low dPG. Thus, 
cellular senescence may underlie the reductions of 
phagocytosis and cell adhesiveness, as well as the 
b
Fig. 4. Evaluation of cell senescence
Cell senescence level was examined by quantitation of interleukin (IL)-6 expression (n = 6 per group (a)) and senescence-
associated beta-galactosidase (Sa-βG) activity (n = 7 per group (b)).
White bar, low degree of pigmentation (dPG) group; black bar, high dPG group
a
a
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enhancement of VEGF secretion, in RPE cells with 
high dPG.
   Royal College of Surgeons rats, which exhibit 
abnormal RPE phagocytic capacity, form a normal 
retinal layer structure before birth; however, outer 
segments of photoreceptor cells accumulate by 
approximately 1 month after birth, resulting in 
photoreceptor cell degeneration18）. This genetic 
abnormality in Royal College of Surgeons rats is 
known to be caused by the aberrant expression of 
MERTK, a tyrosine kinase receptor19）. Additionally, 
reduction of the phagocytic capacity of RPE 
cells due to AMD, along with the accumulation 
of cell  debris in the retina, is presumed to 
generate oxidative stress that causes chronic 
inflammation, eventually leading to choroidal 
neovascularization20）. Therefore, reduced phagocytic 
capacity is undesirable for cells that will be 
transplanted to patients with AMD.
   The dPG in RPE cells increases over time; 
therefore, it is regarded as an indicator of RPE 
maturity11）. Furthermore, secretion of cytokines 
and expression of RPE-specific genes reportedly 
increase in relation to enhanced dPG in the RPE５）. 
Thus, we hypothesized that RPE cells with high dPG 
would have improved cellular function, compared 
with RPE cells with low dPG, which would indicate 
that RPE cells with high dPG might be suitable for 
transplantation to patients with AMD. However, 
our results did not support this hypothesis. This 
surprising finding is valuable, in that it contradicts 
the existing notion that RPE cells exhibit increased 
function with increased dPG.
   We speculate that cellular senescence is involved 
in the mechanism that  causes reduction of 
phagocytic capacity and cell adhesiveness in RPE 
cells with high dPG, combined with the increased 
secretion of VEGF by these cells. Indeed, aging 
is presumed to contribute to the reduction of the 
phagocytic capacity of RPE cells, which leads to the 
onset of AMD. Moreover, compared with normal 
eyes, eyes with AMD reportedly show greater 
accumulation of lipofuscin, the senility pigment21）; 
drusen accumulate in the macula as waste products 
due to the reduced phagocytic capacity of RPE 
cells20，21）. With respect to cell adhesiveness and 
cellular senescence, matrix metalloproteinase, 
which increases during aging of RPE cells, has 
been shown to induce integrin inactivation by 
processing extracellular matrix, thereby attenuating 
cell adhesiveness22）. IL-6 exhibited significantly 
elevated expression in RPE cells with high dPG; this 
cytokine is known to enhance VEGF expression23）.
   Transplantation of RPE cells has not achieved 
improved visual acuity in patients with AMD, 
although it has been successful in reducing disease 
activity. Thus, we presumed that transplantation 
of RPE cells with suitable quality could improve 
visual function in patients with AMD; this study 
was conducted to identify RPE cells with improved 
function. Our results suggested that RPE cells with 
low dPG might serve as high-quality transplants. 
Therefore, the identification of cells with low dPG 
and suitable quality, prior to transplantation, shows 
promise for improving visual function and long-
term prognosis in patients with AMD.
   An important limitation of this study is that it 
only involved in vitro cell culture experiments; 
thus, the findings must be confirmed in future 
animal experiments. Specifically, the effects of 
phagocytosis, cell adhesiveness, and VEGF must 
be assessed in vivo after subretinal transplantation 
of RPE cells with high or low dPG to experimental 
animals. An additional limitation should be 
noted regarding the phagocytosis assay: FACS 
was performed after cells had been washed with 
phosphate-buffered saline to remove beads that 
were bound to the cell surface, but had not been 
phagocytosed. Importantly, this procedure did not 
allow full discrimination of phagocytosed beads 
from bound beads, which may have influenced the 
phagocytosis findings.
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   RPE cells with low dPG showed elevated 
phagocytosis and cell adhesiveness, as well as 
reduced secretion of VEGF, compared with RPE 
cells with high dPG, suggesting that the RPE cells 
with low dPG might be suitable for transplantation 
to patients with AMD, based on the cell biological 
data shown here. Our results also showed that 
cellular senescence was more advanced in RPE cells 
with high dPG than in RPE cells with low dPG, 
suggesting that cellular senescence is involved in 
the mechanism that causes reduction of phagocytic 
capacity and cell adhesiveness in RPE cells with 
high dPG, combined with the increased secretion of 
VEGF by these cells.
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